James A. Reinstein
James is an experienced medical-devices industry leader who was appointed as President, CEO and a member of the Board of Directors in January 2017. Prior to joining Cutera, he served as the CEO of Drawbridge Health Inc., a joint venture of GE Ventures and GE Healthcare. Prior to Drawbridge, Mr. Reinstein was the CEO of Aptus Endosystems from 2012 until its acquisition by Medtronic in 2015. From 2007-2012, he was the EVP and Chief Commercial Officer of Cyberonics, Inc. At Cyberonics, Mr. Reinstein drove the epilepsy strategy for many of its departments including Research & Development, Clinical Research, and New Business Development and led a global commercial team of over 200 employees, growing revenues by 250% within three years. Prior to Cyberonics, Mr. Reinstein held a variety of management positions of increasing responsibility within Boston Scientific Corporation from 1990-2007, including Vice President and Regional Head of an Asian business unit and Country Director of Boston Scientific de Mexico. He began his career with Proctor & Gamble.
James graduated with a BBA in Marketing from University of Georgia, completed courses in Executive Management from INSEAD, France, and has completed numerous other training courses focused on management, negotiations and public speaking.